Sökning: "cancer sahlgrenska"
Visar resultat 1 - 5 av 21 avhandlingar innehållade orden cancer sahlgrenska.
1. Folates in the treatment of colorectal cancer
Sammanfattning : ABSTRACT Folates in the Treatment of Colorectal Cancer Department of Surgery Institute of Clinical Sciences at Sahlgrenska Academy University of Gothenburg Helena Taflin Background: Colorectal cancer is one of the most common cancers in the world, and radical surgery with total removal of the tumour (RO-resection) is the single most important treatment. However, chemotherapy is recommended for patients with risk factors and patients with metastatic disease. LÄS MER
2. Multiple primary malignancies in breast cancer patients. From population study to genetics
Sammanfattning : Breast cancer (BC) is one of the most common causes of cancer-related death among women worldwide. Due to early detection of BC and more tailor-made treatments, patients live longer despite their illness. Studies have shown that BC patients are at risk of developing new tumors in organs other than the breast, mainly caused by BC treatment. LÄS MER
3. Optimizing postoperative radiation therapy in prostate cancer: focus on side-effects, practical implementation and dose distribution
Sammanfattning : Optimizing postoperative radiotherapy in prostate cancer: focus on side effects, practical implementation and dose distribution Karin Braide, MD Department of Urology, Institute of Clincal Sciences Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden ABSTRACT We analyzed side-effects, pre-treatment bladder preparations and dose distribution to the rectum in four different cohorts of patients, treated with postoperative radiotherapy (PRT) in prostate cancer. Side-effects according to a self-reporting survey revealed rectal bleeding as a main result in a follow up time of 6. LÄS MER
4. Targeted radionuclide therapy for patients with neuroendocrine tumours with focus on normal tissue response in 177-Lu-DOTATATE treatment
Sammanfattning : Targeted radionuclide therapy with 177Lu-DOTATATE for patients with neuroendocrine tumours utilises the frequent overexpressing of somatostatin receptors on the tumour cells. This treatment modality has demonstrated valuable patient benefits and is well tolerated. However, renal and bone marrow toxicity can become dose limiting and persisting. LÄS MER
5. Prognostic and predictive factors in laryngeal cancer treated with radiotherapy
Sammanfattning : Radiotherapy (RT) and surgery are the only two curative treatments for patients with laryngeal cancer (LC). RT has the advantage that it offers a possibility to preserve a functioning larynx and hence a functioning normal voice. The response of tumors to RT is heterogeneous, even within the same tumor stage. LÄS MER
